The scope of this review is to correlate the impact of PTX3 in DM and progression of complications, as well as antidiabetic drugs’ influence, considering that inflammatory pathways are pillars in the evolution of this metabolic disease. The gene discussed is PTX3; the disease is diabetes mellitus.